Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

May 04, 2022

BUY
$57.56 - $82.54 $736,768 - $1.06 Million
12,800 Added 164.1%
20,600 $1.44 Million
Q2 2020

Aug 13, 2020

BUY
$55.75 - $92.75 $128,225 - $213,325
2,300 Added 41.82%
7,800 $678,000
Q4 2017

Feb 14, 2018

SELL
$46.49 - $60.51 $929,800 - $1.21 Million
-20,000 Reduced 78.43%
5,500 $288,000
Q3 2017

Nov 14, 2017

SELL
$37.05 - $47.12 $29,639 - $37,696
-800 Reduced 3.04%
25,500 $1.2 Million
Q2 2017

Aug 14, 2017

BUY
N/A
26,300
26,300 $930,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.9B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Wolverine Asset Management LLC Portfolio

Follow Wolverine Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Asset Management LLC with notifications on news.